{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28990985",
  "DateCompleted": {
    "Year": "2018",
    "Month": "06",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "02",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/GRF.0000000000000320"
    ],
    "Journal": {
      "ISSN": "1532-5520",
      "JournalIssue": {
        "Volume": "60",
        "Issue": "4",
        "PubDate": {
          "Year": "2017",
          "Month": "Dec"
        }
      },
      "Title": "Clinical obstetrics and gynecology",
      "ISOAbbreviation": "Clin Obstet Gynecol"
    },
    "ArticleTitle": "Endometriosis-associated Ovarian Cancers.",
    "Pagination": {
      "StartPage": "711",
      "EndPage": "727",
      "MedlinePgn": "711-727"
    },
    "Abstract": {
      "AbstractText": [
        "Endometriosis-associated cancers include clear cell and endometrioid ovarian carcinoma. A history of endometriosis has long been considered to be a risk factor for later development of these malignancies; however, recent molecular genetic evidence has provided unequivocal evidence that these lesions are in fact the precursors for endometriosis-associated cancers. Herein, we will explore the relationship between endometriosis and ovarian carcinomas, similarities between the premalignant lesions and their cancerous counterparts, and the potential role of mutations and the ovarian microenvironment that may contribute to malignant transformation."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "*Department of Obstetrics and Gynaecology, OVCARE, Robert HN Ho Research Centre, Vancouver, British Columbia, Canada \u2020Department of Obstetrics and Gynaecology, BC Women's Centre for Pelvic Pain and Endometriosis, University of British Columbia, Vancouver, British Columbia, Canada."
          }
        ],
        "LastName": "Anglesio",
        "ForeName": "Michael S",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yong",
        "ForeName": "Paul J",
        "Initials": "PJ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Obstet Gynecol",
    "NlmUniqueID": "0070014",
    "ISSNLinking": "0009-9201"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma, Clear Cell"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Carcinoma, Endometrioid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carcinoma, Ovarian Epithelial"
    },
    {
      "QualifierName": [
        "complications",
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Endometriosis"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Endometrium"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Neoplasms, Glandular and Epithelial"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Ovary"
    }
  ]
}